Merck KGaA (OTCMKTS:MKGAF) Shares Gap Up – Time to Buy?

Merck KGaA (OTCMKTS:MKGAF) shares gapped up before the market opened on Friday . The stock had previously closed at $151.95, but opened at $159.1320. Merck KGaA shares last traded at $159.0510, with a volume of 25 shares traded.

Merck KGaA Stock Up 4.6%

The company has a debt-to-equity ratio of 0.27, a current ratio of 1.31 and a quick ratio of 0.84. The company has a market cap of $20.54 billion, a P/E ratio of 24.26 and a beta of 0.96. The stock has a 50-day moving average of $162.66 and a 200 day moving average of $149.52.

Hedge Funds Weigh In On Merck KGaA

Several hedge funds have recently bought and sold shares of the company. Elefante Mark B acquired a new position in shares of Merck KGaA in the 2nd quarter valued at approximately $617,000. Ames National Corp bought a new stake in shares of Merck KGaA during the 2nd quarter worth approximately $1,009,000. Notis McConarty Edward acquired a new stake in shares of Merck KGaA during the 2nd quarter worth approximately $1,304,000. North Star Asset Management Inc. acquired a new stake in shares of Merck KGaA during the 2nd quarter worth approximately $1,411,000. Finally, Pinnacle Holdings LLC bought a new position in Merck KGaA in the second quarter valued at approximately $1,487,000. 0.10% of the stock is owned by institutional investors.

About Merck KGaA

Merck KGaA is a Germany-based science and technology company headquartered in Darmstadt. Founded in 1668, it is one of the world’s oldest operating pharmaceutical and chemical companies. The business serves customers in more than 60 countries through three operating sectors: Healthcare, Life Science and Electronics.

The Healthcare sector develops and markets prescription medicines and specialty therapies, with activities focused on areas including oncology, neurology and immunology, fertility, and endocrinology.